Editor's Note
The Food and Drug Administration (FDA) on August 9 identified the recall by Haimen Shengbang Laboratory Equipment Co Ltd of its Viral Transport Media Containers as Class I, the most serious.
The recall was initiated because the products were distributed in the US without authorization, clearance, or approval by the FDA.
The container and swab are used to collect specimens from patients for transport to a laboratory for viral testing to detect infections, including the virus that causes COVID-19.
To date, there have been no complaints, reports of injuries, or deaths associated with this product. Distribution dates were October 8, 2021, to February 15, 2022. More than 4 million were recalled in the US.
Read More >>Certain perioperative leaders stand out for their ability to inspire…
Takeaways • Although the central tenets of value-based healthcare have…
Takeaways • Interdepartmental collaboration and standardized communication are essential to…